Fallbericht
Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
Journal of Drugs in Dermatology · 2024
DOI: 10.36849/jdd.7782 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Yazmeen Tembunde und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Alopecia Areata, Janus Kinase Inhibitors, Nitriles, Pyrazoles. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Alopecia AreataJanus Kinase InhibitorsNitrilesPyrazolesPyrimidinesChildHumansAdministration, CutaneousSkin CreamTreatment Outcome
Substanzen
Janus Kinase InhibitorsNitrilesPyrazolesPyrimidinesruxolitinib
Zitieren
APA
Tembunde, Y., & Kindred, C. (2024). Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7782
Vancouver
Tembunde Y, Kindred C. Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.7782
BibTeX
@article{Tembunde2024,
author = {Tembunde, Yazmeen and Kindred, Chesahna},
title = {Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata},
journal = {Journal of Drugs in Dermatology},
year = {2024},
doi = {10.36849/jdd.7782}
}
EUVIMED